Cover Image
Market Research Report

In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product, By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease, Oncology/Cancer), By End Use, And Segment Forecasts, 2019 - 2026

Published by Grand View Research, Inc. Product code 656140
Published Content info 159 Pages
Delivery time: 2-3 business days
Price
Back to Top
In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product, By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease, Oncology/Cancer), By End Use, And Segment Forecasts, 2019 - 2026
Published: April 30, 2019 Content info: 159 Pages
Description

Industry Insights

The global In Vitro Diagnostics market size was valued at USD 69.6 billion in 2018 and is estimated to register a CAGR of 4.75% from 2019 to 2026. Growing geriatric population, which is susceptible to various diseases and requires regular diagnostic tests, is expected to be one of the high impact rendering drivers for the market. Furthermore, new product launch and technological developments, in terms of cost-effectiveness, accuracy, and portability, are expected to propel the market growth over the forecast years.

For instance, in December 2018, Novacyt launched its new CE-IVD mark molecular diagnostic kits called Genesig Real-Time PCR Epstein-Barr Virus (EBV) Kit and Genesig Real-Time PCR BK virus (BKV) Kit. In addition, in July 2018, Surmodics, Inc., launched an assay "MatrixGuard Diluent" to reduce false positive results in IVD tests. Rising prevalence of various diseases, such as cancer, autoimmune diseases, and inflammatory diseases, is expected to drive the demand for IVD testing.

image1

For instance, according to National Institute of Health (NIH), in 2017, approximately 23.5 Million cases of autoimmune diseases were reported in America and this number is expected to increase over the forecast period. Increasing tobacco and alcohol consumption, sedentary lifestyle, unhealthy dietary habits, etc. are the major factors responsible for increased prevalence of cancer. The number of cancer cases is expected to increase in low- and middle-income countries owing to lack of advanced healthcare infrastructure and availability of resources.

Rising demand for Point-of-Care (PoC) devices is expected to fuel the market growth further. In addition, introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth.

Report Coverage & Deliverables

image2

Product Insights

On the basis of product, the market is segmented into instruments, reagents, and services. Reagents was the dominant product segment in 2018 due to high usage of these products in IVD testing. Rise in the number of R&D initiatives related to reagents and demand for self-test and PoC devices are also likely to boost the segment growth. On the other hand, instruments are expected to witness the highest CAGR during the forecast period. In April 2018, Altona Diagnostics GmbH, launched a CE-IVD marked AltoStar Molecular Diagnostics Workflow. It is a flexible and efficient automatic system that automates the entire workflow from sample preparation till analysis.

Technology Insights

On the basis of technology, market is segmented into immunoassay, clinical chemistry, hematology, molecular diagnostics, microbiology, coagulation, and others. Immunoassay led global market in 2018. Increasing incidence of chronic and communicable diseases and rising need for early diagnosis are the key factors attributed to the largest share of this technology segment. Molecular diagnostics is expected to witness the fastest CAGR over the forecast period. Molecular diagnostics enables early detection of cancer, infectious diseases, and genetic disorders by using genetic technologies and has applications in detection of abnormalities in the prenatal stage.

Application Insights

On the basis of application, the market is segmented into infectious disease, cardiology diabetes, cancer, drug testing, nephrology, autoimmune diseases, and others. The infectious disease segment dominated the market with a revenue of around USD 17 billion in 2018. Oncology is expected to be the fastest-growing application segment during the forecast years. The segment is driven by several factors, such as increasing demand for self-care devices and POC diagnostics, for the treatment of chronic diseases.

End Use Insights

On the basis of end use, the market is segmented into hospitals, laboratories, home care, and others. IVD services are used by hospitals and laboratories as well as directly by patients.

image3

Hospitals segment accounted for the largest share of 45.68% in 2018, owing to high demand for IVD tests as a result of rise in hospitalization, whereas homecare is expected to be the fastest-growing segment over the forecast period.

Regional Insights

North America held the largest market share of 46.23% in 2018. Favorable government regulations, well-established diagnostic infrastructure, technological advancements, and presence of key market participants in this region are the factors responsible for its largest share.

On the other hand, Asia Pacific is expected to witness the fastest growth over the forecast period. Presence of target population base and rapidly improving healthcare infrastructure in Asia Pacific are anticipated to boost the market growth over the next few years.

In Vitro Diagnostics (IVD) Market Share Insights

Some of the key companies in the global market are Siemens Healthineers; Qiagen; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Hologic, Inc. (Gen-Probe); Abbott Laboratories; Danaher Corp.; Sysmex Corp.; and Cepheid, Inc.

These companies focus on strategies, such as M&A, collaborations, and new product developments to strengthen their global reach and increase market share. For instance, in August 2018, Sysmex Corp. and JVCKENWOOD Corp. jointly established a new company "Creative Nanosystems Corp." to develop and manufacture biodevices.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historical data

2014 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Million and CAGR from 2018 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S., Canada, U.K., Germany, Spain, France, Italy, Russia, Japan, China, India, South Korea, Singapore, Australia, Brazil, Mexico, Argentina, South Africa, UAE, and Saudi Arabia

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope(equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global In Vitro Diagnostics (IVD) market report on the basis of product, technology, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2026)
    • Instruments
    • Reagents
    • Services
  • Technology Outlook (Revenue, USD Million, 2014 - 2026)
    • Immunolo
      • Instruments
      • Reagents
      • Services
    • Hematology
      • Instruments
      • Reagents
      • Services
    • Clinical Chemistry
      • Instruments
      • Reagents
      • Services
    • Molecular Diagnostics
      • Instruments
      • Reagents
      • Services
    • Coagulation
      • Instruments
      • Reagents
      • Services
    • Microbiology
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Application Outlook (Revenue, USD Million, 2014 - 2026)
    • Infectious Disease
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Diseases
    • Drug Testing
    • Others
  • End Use Outlook (Revenue, USD Million, 2014 - 2026)
    • Hospitals
    • Laboratories
    • Home Care
    • Others
  • Regional Outlook (Revenue, USD Million, 2014 - 2026)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Spain
      • France
      • Italy
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Singapore
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • United Arab Emirates
      • Saudi Arabia
Table of Contents
Product Code: 978-1-68038-080-4

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Market segmentation & scope
  • 1.3. Market definition
  • 1.4. Information procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources & third party perspectives
    • 1.4.4. Primary research
  • 1.5. Information analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & data visualization
  • 1.7. Data validation & publishing

Chapter 2. Executive Summary


  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global IVD Market Variables, Trends & Scope

  • 3.1. IVD Market Lineage outlook
    • 3.1.1. Medical Technology market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement framework
    • 3.3.2. Standards & Compliances
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing demand for point of care diagnostics
      • 3.4.1.2. Growing geriatric population
      • 3.4.1.3. Introduction of technologically advanced diagnostics
      • 3.4.1.4. Increasing prevalence of chronic diseases
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High cost of devices
      • 3.4.2.2 Stringent regulatory policies
  • 3.5. Global IVD Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power: (Moderate to high due to presence of many manufacturers)
      • 3.5.1.2. Buyer Power: (Low due to presence of primary clinics and diagnostic labs entering into long-term contract)
      • 3.5.1.3. Substitution Threat: (Moderate to Low due to high Accuracy of diagnostic results)
      • 3.5.1.4. Threat from new entrant: (Moderate due to brand recognition of the existing players)
      • 3.5.1.5. Competitive rivalry: (High due to increasing mergers & acquisitions by major players)
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
      • 3.5.3.1. Joint Ventures
      • 3.5.3.2. Mergers & Acquisitions
      • 3.5.3.3. Licensing & Partnership
      • 3.5.3.4. Technology Collaborations
      • 3.5.3.5. Strategic Divestments

Chapter 4. Global IVD Market - Competitive Analysis

  • 4.1. Recent developments & impact analysis, by key market participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Vendor Landscape
    • 4.3.1. List of key distributors and channel partners
    • 4.3.2. Key company market share analysis, 2018
  • 4.4. Public Companies
    • 4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2. Company Market Share
    • 4.4.3. Competitive Dashboard Analysis
    • 4.4.4. Market Differentiators
    • 4.4.5. Synergy Analysis: Major Deals & Strategic Alliances
  • 4.5. Private Companies
    • 4.5.1. List of key emerging companies
    • 4.5.2. Regional network map
    • 4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Global IVD Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Global IVD Market, by Product, 2014 to 2026
  • 5.3. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 5.3.1. Instruments
      • 5.3.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
    • 5.3.2. Reagents
      • 5.3.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
    • 5.3.3. Services
      • 5.3.3.1 Services IVD Market, 2014 - 2026 (USD Million)

Chapter 6. Global IVD Market: Technology Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Technology market share analysis, 2018 & 2026
  • 6.3. Global IVD Market, by Technology, 2014 to 2026
  • 6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 6.4.1. Immunoassay
      • 6.4.1.1 Immunoassay IVD Market, 2014 - 2026 (USD Million)
    • 6.4.2. Hematology
      • 6.4.2.1 Hematology IVD Market, 2014 - 2026 (USD Million)
    • 6.4.3. Clinical Chemistry
      • 6.4.3.1 Clinical Chemistry IVD Market, 2014 - 2026 (USD Million)
    • 6.4.4. Molecular Diagnostics
      • 6.4.4.1 Molecular Diagnostics IVD Market, 2014 - 2026 (USD Million)
    • 6.4.5. Coagulation
      • 6.4.5.1 Coagulation IVD Market, 2014 - 2026 (USD Million)
    • 6.4.6. Microbiology
      • 6.4.6.1 Microbiology IVD Market, 2014 - 2026 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1 Others IVD Market, 2014 - 2026 (USD Million)
  • 6.5. Technology Markets, by Product, 2014 to 2026:
    • 6.5.1. Immunoassay
      • 6.5.1.1 Instruments
        • 6.5.1.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.2.1 Reagents
        • 6.5.2.1.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.3.1 Services
        • 6.5.3.1.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.2. Hematology
      • 6.5.2.1 Instruments
        • 6.5.2.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.2.2. Reagents
        • 6.5.2.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.2.3 Services
        • 6.5.2.3.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.3. Clinical Chemistry
      • 6.5.3.1 Instruments
        • 6.5.3.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.3.2. Reagents
        • 6.5.3.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.3.3 Services
        • 6.5.3.3.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.4. Molecular Diagnostics
      • 6.5.4.1 Instruments
        • 6.5.4.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.4.2. Reagents
        • 6.5.4.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.4.3 Services
        • 6.5.4.3.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.5. Coagulation
      • 6.5.5.1 Instruments
        • 6.5.5.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.5.2. Reagents
        • 6.5.5.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.5.3 Services
        • 6.5.5.3.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.6. Microbiology
      • 6.5.6.1 Instruments
        • 6.5.6.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.6.2. Reagents
        • 6.5.6.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.6.3 Services
        • 6.5.6.3.1 Services IVD Market, 2014 - 2026 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1 Instruments
        • 6.5.7.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
      • 6.5.7.2. Reagents
        • 6.5.7.2.1 Reagents IVD Market, 2014 - 2026 (USD Million)
      • 6.5.7.3 Services
        • 6.5.7.3.1 Services IVD Market, 2014 - 2026 (USD Million)

Chapter 7. Global IVD Market: Application Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Application market share analysis, 2018 & 2026
  • 7.3. Global IVD Market, by Application, 2014 to 2026
  • 7.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 7.4.1. Infectious Disease
      • 7.4.1.1 Infectious Disease IVD Market, 2014 - 2026 (USD Million)
    • 7.4.2. Diabetes
      • 7.4.2.1 Diabetes IVD Market, 2014 - 2026 (USD Million)
    • 7.4.3. Oncology
      • 7.4.3.1 Oncology IVD Market, 2014 - 2026 (USD Million)
    • 7.4.4. Cardiology
      • 7.4.4.1 Cardiology IVD Market, 2014 - 2026 (USD Million)
    • 7.4.5. Nephrology
      • 7.4.5.1 Nephrology IVD Market, 2014 - 2026 (USD Million)
    • 7.4.6. Autoimmune Disease
      • 7.4.6.1 Autoimmune Disease IVD Market, 2014 - 2026 (USD Million)
    • 7.4.7. Drug Testing
      • 7.4.7.1 Drug Testing IVD Market, 2014 - 2026 (USD Million)
    • 7.4.8. Others
      • 7.4.8.1 Others IVD Market, 2014 - 2026 (USD Million)

Chapter 8. Global IVD Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions & Scope
  • 8.2. End use market share analysis, 2018 & 2026
  • 8.3. Global IVD Market, by End-use, 2014 to 2026
  • 8.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 8.4.1. Hospitals
      • 8.4.1.1 Instrument IVD Market, 2014 - 2026 (USD Million)
    • 8.4.2. Laboratories
      • 8.4.2.1 Instrument IVD Market, 2014 - 2026 (USD Million)
    • 8.4.3. Home Care
      • 8.4.3.1 Instrument IVD Market, 2014 - 2026 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1 Instrument IVD Market, 2014 - 2026 (USD Million)

Chapter 9 Global IVD Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & End-use

  • 9.1 Global IVD Market: Regional Movement Analysis, 2018 & 2026
  • 9.2 Global IVD Market: Leading Players, 2018:
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4 North America
    • 9.4.1 North America IVD market, 2014 - 2026 (USD Million)
    • 9.4.2 U.S.
      • 9.4.2.1 U.S. IVD Market, 2014 - 2026 (USD Million)
    • 9.4.3 Canada
      • 9.4.3.1 Canada IVD Market, 2014 - 2026 (USD Million)
  • 9.5. Europe
    • 9.5.1 Europe IVD market, 2014 - 2026 (USD Million)
    • 9.5.2 U.K.
      • 9.5.2.1 U.K. IVD market, 2014 - 2026 (USD Million)
    • 9.5.3 Germany
      • 9.5.3.1 Germany IVD market, 2014 - 2026 (USD Million)
    • 9.5.4 Spain
      • 9.5.4.1 Spain IVD market, 2014 - 2026 (USD Million)
    • 9.5.5 France
      • 9.5.5.1 France IVD market, 2014 - 2026 (USD Million)
    • 9.5.6 Italy
      • 9.5.6.1 Italy IVD market, 2014 - 2026 (USD Million)
    • 9.5.7 Russia
      • 9.5.7.1 Russia IVD market, 2014 - 2026 (USD Million)
  • 9.6 Asia Pacific
    • 9.6.1 Asia Pacific IVD market, 2014 - 2026 (USD Million)
    • 9.6.2 Japan
      • 9.6.2.1 Japan IVD market, 2014 - 2026 (USD Million)
    • 9.6.3 China
      • 9.6.3.1 China IVD market, 2014 - 2026 (USD Million)
    • 9.6.4 India
      • 9.6.4.1 India IVD market, 2014 - 2026 (USD Million)
    • 9.6.5 South Korea
      • 9.6.5.1 South Korea IVD market, 2014 - 2026 (USD Million)
    • 9.6.6 Singapore
      • 9.6.6.1 Singapore IVD market, 2014 - 2026 (USD Million)
    • 9.6.7 Australia
      • 9.6.7.1 Australia IVD market, 2014 - 2026 (USD Million)
  • 9.7 Latin America
    • 9.7.1 Latin America IVD market, 2014 - 2026 (USD Million)
    • 9.7.2 Brazil
      • 9.7.2.1 Brazil IVD market, 2014 - 2026 (USD Million)
    • 9.7.3 Mexico
      • 9.7.3.1 Mexico IVD market, 2014 - 2026 (USD Million)
    • 9.7.4 Argentina
      • 9.7.4.1 Argentina IVD market, 2014 - 2026 (USD Million)
  • 9.8 MEA
    • 9.8.1 MEA IVD market, 2014 - 2026 (USD Million)
    • 9.8.2 South Africa
      • 9.8.2.1 South Africa IVD market, 2014 - 2026 (USD Million)
    • 9.8.3 United Arab Emirates
      • 9.8.3.1 United Arab Emirates IVD market, 2014 - 2026 (USD Million)
    • 9.8.4 Saudi Arabia
      • 9.8.4.1 Saudi Arabia IVD market, 2014 - 2026 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
  • 10.2 Heat Map Analysis of Private Companies
    • 10.2.1 Company size
    • 10.2.2 Distribution network
    • 10.2.3 Product portfolio
    • 10.2.4 Segment coverage
    • 10.2.5 Geographic presence
    • 10.2.6 Collaborations
    • 10.2.7 Conclusion
  • 10.3 Becton, Dickinson and Company
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 bioMerieux
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 Abbott Laboratories
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Sysmex Corporation
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Ortho Clinical Diagnostics
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives
  • 10.8 Danaher
    • 10.8.1 Company overview
    • 10.8.2 Financial performance
    • 10.8.3 Product benchmarking
    • 10.8.4 Strategic initiatives
  • 10.9 Hologic, Inc. (Gen Probe)
    • 10.9.1 Company overview
    • 10.9.2 Financial performance
    • 10.9.3 Product benchmarking
    • 10.9.4 Strategic initiatives
  • 10.10 Cepheid
    • 10.10.1 Company overview
    • 10.10.2 Product benchmarking
    • 10.10.3 Strategic initiatives
  • 10.11 F. Hoffmann-La Roche Ltd
    • 10.11.1 Company Overview
    • 10.11.2 Financial performance
    • 10.11.3 Product benchmarking
    • 10.11.4 Strategic initiatives
  • 10.12 Siemens Healthineers
    • 10.12.1 Company overview
    • 10.12.2 Financial performance
    • 10.12.3 Product benchmarking
    • 10.12.4 Strategic initiatives
  • 10.13 Instrumentation Laboratory
    • 10.13.1 Company overview
    • 10.13.2 Financial overview
    • 10.13.3 Product benchmarking
    • 10.13.4 Strategic initiatives
  • 10.14 Leica Biosystems Nussloch Gmbh
    • 10.14.1 Company overview
    • 10.14.2 Product benchmarking
    • 10.14.3 Strategic initiatives
  • 10.15 Bio-Rad Laboratories, Inc.
    • 10.15.1 Company overview
    • 10.15.2 Financial performance
    • 10.15.3 Product benchmarking
    • 10.15.4 Strategic initiatives
  • 10.16 Quidel Corporation
    • 10.16.1 Company overview
    • 10.16.2 Financial performance
    • 10.16.3 Products benchmarking
    • 10.16.4 Strategic initiatives
  • 10.17 Qiagen N.V.
    • 10.17.1 Company overview
    • 10.17.2 Financial performance
    • 10.17.3 Product benchmarking
    • 10.17.4 Strategic initiatives
  • 10.18 OraSure Technologies, Inc.
    • 10.18.1 Company overview
    • 10.18.2 Financial performance
    • 10.18.3 Products benchmarking
    • 10.18.4 Strategic initiatives
  • 10.19 Stago
    • 10.19.1 Company overview
    • 10.19.2 Product benchmarking
    • 10.19.3 Strategic initiatives

List of Tables

  • TABLE 1 North America IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 2 North America IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 3 North America Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 4 North America Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 5 North America Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 6 North America Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 7 North America Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 8 North America Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 9 North America Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 10 North America IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 11 North America IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 12 U.S. IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 13 U.S. IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 14 U.S. Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 15 U.S. Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 16 U.S. Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 17 U.S. Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 18 U.S. Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 19 U.S. Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 20 U.S. Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 21 U.S. IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 22 U.S. IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 23 Canada IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 24 Canada IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 25 Canada Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 26 Canada Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 27 Canada Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 28 Canada Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 29 Canada Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 30 Canada Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 31 Canada Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 32 Canada IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 33 Canada IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 34 Europe IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 35 Europe IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 36 Europe Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 37 Europe Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 38 Europe Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 39 Europe Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 40 Europe Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 41 Europe Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 42 Europe Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 43 Europe IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 44 Europe IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 45 U.K. IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 46 U.K. IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 47 U.K. Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 48 U.K. Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 49 U.K. Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 50 U.K. Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 51 U.K. Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 52 U.K. Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 53 U.K. Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 54 U.K. IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 55 U.K. IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 56 Germany IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 57 Germany IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 58 Germany Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 59 Germany Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 60 Germany Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 61 Germany Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 62 Germany Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 63 Germany Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 64 Germany Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 65 Germany IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 66 Germany IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 67 Spain IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 68 Spain IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 69 Spain Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 70 Spain Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 71 Spain Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 72 Spain Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 73 Spain Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 74 Spain Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 75 Spain Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 76 Spain IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 77 Spain IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 78 France IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 79 France IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 80 France Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 81 France Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 82 France Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 83 France Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 84 France Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 85 France Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 86 France Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 87 France IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 88 France IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 89 Italy IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 90 Italy IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 91 Italy Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 92 Italy Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 93 Italy Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 94 Italy Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 95 Italy Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 96 Italy Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 97 Italy Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 98 Italy IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 99 Italy IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 100 Russia IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 101 Russia IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 102 Russia Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 103 Russia Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 104 Russia Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 105 Russia Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 106 Russia Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 107 Russia Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 108 Russia Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 109 Russia IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 110 Russia IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 111 Asia Pacific IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 112 Asia Pacific IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 113 Asia Pacific Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 114 Asia Pacific Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 115 Asia Pacific Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 116 Asia Pacific Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 117 Asia Pacific Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 118 Asia Pacific Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 119 Asia Pacific Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 120 Asia Pacific IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 121 Asia Pacific IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 122 Japan IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 123 Japan IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 124 Japan Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 125 Japan Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 126 Japan Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 127 Japan Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 128 Japan Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 129 Japan Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 130 Japan Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 131 Japan IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 132 Japan IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 133 China IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 134 China IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 135 China Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 136 China Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 137 China Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 138 China Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 139 China Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 140 China Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 141 China Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 142 China IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 143 China IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 144 India IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 145 India IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 146 India Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 147 India Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 148 India Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 149 India Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 150 India Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 151 India Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 152 India Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 153 India IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 154 India IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 155 South Korea IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 156 South Korea IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 157 South Korea Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 158 South Korea Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 159 South Korea Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 160 South Korea Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 161 South Korea Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 162 South Korea Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 163 South Korea Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 164 South Korea IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 165 South Korea IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 166 Singapore IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 167 Singapore IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 168 Singapore Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 169 Singapore Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 170 Singapore Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 171 Singapore Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 172 Singapore Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 173 Singapore Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 174 Singapore Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 175 Singapore IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 176 Singapore IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 177 Australia IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 178 Australia IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 179 Australia Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 180 Australia Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 181 Australia Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 182 Australia Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 183 Australia Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 184 Australia Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 185 Australia Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 186 Australia IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 187 Australia IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 188 Latin America IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 189 Latin America IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 190 Latin America Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 191 Latin America Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 192 Latin America Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 193 Latin America Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 194 Latin America Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 195 Latin America Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 196 Latin America Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 197 Latin America IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 198 Latin America IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 199 Brazil IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 200 Brazil IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 201 Brazil Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 202 Brazil Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 203 Brazil Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 204 Brazil Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 205 Brazil Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 206 Brazil Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 207 Brazil Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 208 Brazil IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 209 Brazil IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 210 Mexico IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 211 Mexico IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 212 Mexico Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 213 Mexico Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 214 Mexico Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 215 Mexico Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 216 Mexico Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 217 Mexico Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 218 Mexico Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 219 Mexico IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 220 Mexico IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 221 Argentina IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 222 Argentina IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 223 Argentina Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 224 Argentina Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 225 Argentina Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 226 Argentina Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 227 Argentina Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 228 Argentina Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 229 Argentina Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 230 Argentina IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 231 Argentina IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 232 MEA IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 233 MEA IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 234 MEA Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 235 MEA Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 236 MEA Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 237 MEA Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 238 MEA Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 239 MEA Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 240 MEA Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 241 MEA IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 242 MEA IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 243 South Africa IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 244 South Africa IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 245 South Africa Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 246 South Africa Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 247 South Africa Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 248 South Africa Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 249 South Africa Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 250 South Africa Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 251 South Africa Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 252 South Africa IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 253 South Africa IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 254 UAE IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 255 UAE IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 256 UAE Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 257 UAE Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 258 UAE Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 259 UAE Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 260 UAE Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 261 UAE Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 262 UAE Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 263 UAE IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 264 UAE IVD Market, by End-use, 2014 - 2026 (USD Million)
  • TABLE 265 Saudi Arabia IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 266 Saudi Arabia IVD Market, by Technique, 2014 - 2026 (USD Million)
  • TABLE 267 Saudi Arabia Immunoassay IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 268 Saudi Arabia Hematology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 269 Saudi Arabia Clinical Chemistry IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 270 Saudi Arabia Molecular Diagnostics IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 271 Saudi Arabia Coagulation IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 272 Saudi Arabia Microbiology IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 273 Saudi Arabia Others IVD Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 274 Saudi Arabia IVD Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 275 Saudi Arabia IVD Market, by End-use, 2014 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global IVD - Key market driver analysis
  • FIG. 7 Global IVD market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global IVD market - Porter's analysis
  • FIG. 10 Global IVD market - PESTEL analysis
  • FIG. 11 Global IVD market product outlook key takeaways
  • FIG. 12 Global IVD market: Product movement analysis
  • FIG. 13 Instruments market estimates, 2014 - 2026 (USD Million)
  • FIG. 14 Reagents market estimates, 2014 - 2026 (USD Million)
  • FIG. 15 Services market estimates, 2014 - 2026 (USD Million)
  • FIG. 16 Global IVD market technology outlook key takeaways
  • FIG. 17 Global IVD market: Technology movement analysis
  • FIG. 18 Immunology market estimates, 2014 - 2026 (USD Million)
  • FIG. 19 Hematology market estimates, 2014 - 2026 (USD Million)
  • FIG. 20 Clinical Chemistry market estimates, 2014 - 2026 (USD Million)
  • FIG. 21 Molecular Diagnostics market estimates, 2014 - 2026 (USD Million)
  • FIG. 22 Coagulation market estimates, 2014 - 2026 (USD Million)
  • FIG. 23 Microbiology market estimates, 2014 - 2026 (USD Million)
  • FIG. 24 Others market estimates, 2014 - 2026 (USD Million)
  • FIG. 25 Global IVD market application outlook key takeaways
  • FIG. 26 Global IVD market: Application movement analysis
  • FIG. 27 Infectious Diseases market estimates, 2014 - 2026 (USD Million)
  • FIG. 28 Diabetes market estimates, 2014 - 2026 (USD Million)
  • FIG. 29 Oncology market estimates, 2014 - 2026 (USD Million)
  • FIG. 30 Cardiology market estimates, 2014 - 2026 (USD Million)
  • FIG. 31 Nephrology market estimates, 2014 - 2026 (USD Million)
  • FIG. 32 Autoimmune Diseases market estimates, 2014 - 2026 (USD Million)
  • FIG. 33 Drug Testing market estimates, 2014 - 2026 (USD Million)
  • FIG. 34 Others market estimates, 2014 - 2026 (USD Million)
  • FIG. 35 Global IVD market end-use outlook key takeaways
  • FIG. 36 Global IVD market: End-use movement analysis
  • FIG. 37 Hospitals market estimates, 2014 - 2026 (USD Million)
  • FIG. 38 Laboratory market estimates, 2014 - 2026 (USD Million)
  • FIG. 39 Home Care market estimates, 2014 - 2026 (USD Million)
  • FIG. 40 Other market estimates, 2014 - 2026 (USD Million)
  • FIG. 41 Regional market place: Key takeaways
  • FIG. 42 Global IVD market: Regional movement analysis
  • FIG. 43 North America IVD market, 2014 - 2026 (USD Million)
  • FIG. 44 U.S. IVD Market, 2014 - 2026 (USD Million)
  • FIG. 45 Canada IVD Market, 2014 - 2026 (USD Million)
  • FIG. 46 Europe IVD market, 2014 - 2026 (USD Million)
  • FIG. 48 U.K. IVD market, 2014 - 2026 (USD Million)
  • FIG. 49 Germany IVD market, 2014 - 2026 (USD Million)
  • FIG. 50 Spain IVD market, 2014 - 2026 (USD Million)
  • FIG. 51 France IVD market, 2014 - 2026 (USD Million)
  • FIG. 52 Italy IVD market, 2014 - 2026 (USD Million)
  • FIG. 53 Russia IVD market, 2014 - 2026 (USD Million)
  • FIG. 54 Asia Pacific IVD market, 2014 - 2026 (USD Million)
  • FIG. 55 Japan IVD market, 2014 - 2026 (USD Million)
  • FIG. 56 China IVD market, 2014 - 2026 (USD Million)
  • FIG. 57 India IVD market, 2014 - 2026 (USD Million)
  • FIG. 58 South Korea IVD market, 2014 - 2026 (USD Million)
  • FIG. 59 Singapore IVD market, 2014 - 2026 (USD Million)
  • FIG. 60 Australia IVD market, 2014 - 2026 (USD Million)
  • FIG. 61 Latin America IVD market, 2014 - 2026 (USD Million)
  • FIG. 62 Brazil IVD market, 2014 - 2026 (USD Million)
  • FIG. 63 Mexico IVD market, 2014 - 2026 (USD Million)
  • FIG. 64 Argentina IVD market, 2014 - 2026 (USD Million)
  • FIG. 65 MEA IVD market, 2014 - 2026 (USD Million)
  • FIG. 66 South Africa IVD market, 2014 - 2026 (USD Million)
  • FIG. 67 UAE market, 2014 - 2026 (USD Million)
  • FIG. 68 Saudi Arabia IVD market, 2014 - 2026 (USD Million)
  • FIG. 69 Strategy framework
  • FIG. 70 Heat map analysis
  • FIG. 71 Becton, Dickinson and Company overview
  • FIG. 72 bioMerieux overview
  • FIG. 73 Abbott Laboratories, Inc. overview
  • FIG. 74 Sysmex Corporation overview
  • FIG. 75 Ortho Clinical Diagnostics overview
  • FIG. 76 Danaher overview
  • FIG. 77 Hologic, Inc. overview
  • FIG. 78 Cepheid overview
  • FIG. 79 F. Hoffmann-La Roche Ltd overview
  • FIG. 80 Siemens Healthineers overview
  • FIG. 81 Stago overview
  • FIG. 82 Instrumentation Laboratory overview
  • FIG. 83 Leica Biosystems Nussloch Gmbh overview

List of Tables

  • TABLE 1 North America IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 2 North America IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 3 North America IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 4 North America IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 5 U.S. IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 8 U.S. IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 11 Canada IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 12 Canada IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 14 Europe IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 15 Europe IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 16 Europe IVD Market, by End-use2014 - 2025 (USD Billion)
  • TABLE 17 UK IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 18 UK IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 19 UK IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 20 UK IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 21 Germany IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 22 Germany IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 23 Germany IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 24 Germany IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 25 Asia Pacific IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 26 Asia Pacific IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 27 Asia Pacific IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 28 Asia Pacific IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 29 Japan IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 30 Japan IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 31 Japan IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 32 Japan IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 33 China IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 34 China IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 35 China IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 36 China IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 37 Latin America IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 38 Latin America IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 39 Latin America IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 40 Latin America IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 41 Brazil IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 42 Brazil IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 43 Brazil IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 44 Brazil IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 45 Mexico IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 46 Mexico IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 47 Mexico IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 48 Mexico IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 49 MEA IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 50 MEA IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 51 MEA IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 52 MEA IVD Market, by End-use, 2014 - 2025 (USD Billion)
  • TABLE 53 South Africa IVD Market, by Product, 2014 - 2025 (USD Billion)
  • TABLE 54 South Africa IVD Market, by Technique, 2014 - 2025 (USD Billion)
  • TABLE 55 South Africa IVD Market, by Application, 2014 - 2025 (USD Billion)
  • TABLE 56 South Africa IVD Market, by End-use, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global IVD - Key market driver analysis
  • FIG. 7 Global IVD market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global IVD market - Porter's analysis
  • FIG. 10 Global IVD market f PESTEL analysis
  • FIG. 11 Global IVD market product outlook key takeaways
  • FIG. 12 Global IVD market: Product movement analysis
  • FIG. 13 Instruments market estimates, 2014 - 2025 (USD Billion)
  • FIG. 14 Reagents market estimates, 2014 - 2025 (USD Billion)
  • FIG. 15 Services market estimates, 2014 - 2025 (USD Billion)
  • FIG. 16 Global IVD market technology outlook key takeaways
  • FIG. 17 Global IVD market: Technology movement analysis
  • FIG. 18 Immunology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 19 Hematology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 20 Clinical Chemistry market estimates, 2014 - 2025 (USD Billion)
  • FIG. 21 Molecular Diagnostics market estimates, 2014 - 2025 (USD Billion)
  • FIG. 22 Coagulation market estimates, 2014 - 2025 (USD Billion)
  • FIG. 23 Microbiology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 24 Others market estimates, 2014 - 2025 (USD Billion)
  • FIG. 25 Global IVD market application outlook key takeaways
  • FIG. 26 Global IVD market: Application movement analysis
  • FIG. 27 Infectious Diseases market estimates, 2014 - 2025 (USD Billion)
  • FIG. 28 Diabetes market estimates, 2014 - 2025 (USD Billion)
  • FIG. 29 Oncology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 30 Cardiology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 31 Nephrology market estimates, 2014 - 2025 (USD Billion)
  • FIG. 32 Autoimmune Diseases market estimates, 2014 - 2025 (USD Billion)
  • FIG. 33 Drug Testing market estimates, 2014 - 2025 (USD Billion)
  • FIG. 34 Others market estimates, 2014 - 2025 (USD Billion)
  • FIG. 35 Global IVD market end-use outlook key takeaways
  • FIG. 36 Global IVD market: End-use movement analysis
  • FIG. 37 Hospitals market estimates, 2014 - 2025 (USD Billion)
  • FIG. 38 Laboratory market estimates, 2014 - 2025 (USD Billion)
  • FIG. 39 Home Care market estimates, 2014 - 2025 (USD Billion)
  • FIG. 40 Other market estimates, 2014 - 2025 (USD Billion)
  • FIG. 41 Regional market place: Key takeaways
  • FIG. 42 Global IVD market: Regional movement analysis
  • FIG. 43 North America IVD market, 2014 - 2025 (USD Billion)
  • FIG. 44 U.S. IVD Market, 2014 - 2025 (USD Billion)
  • FIG. 45 Canada IVD Market, 2014 - 2025 (USD Billion)
  • FIG. 46 Europe IVD market, 2014 - 2025 (USD Billion)
  • FIG. 47 Germany IVD market, 2014 - 2025 (USD Billion)
  • FIG. 48 UK IVD market, 2014 - 2025 (USD Billion)
  • FIG. 49 Asia Pacific IVD market, 2014 - 2025 (USD Billion)
  • FIG. 50 Japan IVD market, 2014 - 2025 (USD Billion)
  • FIG. 51 China IVD market, 2014 - 2025 (USD Billion)
  • FIG. 52 Latin America IVD market, 2014 - 2025 (USD Billion)
  • FIG. 53 Brazil IVD market, 2014 - 2025 (USD Billion)
  • FIG. 54 Mexico IVD market, 2014 - 2025 (USD Billion)
  • FIG. 55 MEA IVD market, 2014 - 2025 (USD Billion)
  • FIG. 56 South Africa IVD market, 2014 - 2025 (USD Billion)
  • FIG. 57 Strategy framework
  • FIG. 58 Heat map analysis
  • FIG. 59 Becton, Dickinson and Company overview
  • FIG. 60 .bioMerieux overview
  • FIG. 61 Abbott Laboratories, Inc. overview
  • FIG. 62 Sysmex Corporation overview
  • FIG. 63 Ortho Clinical Diagnostics overview
  • FIG. 64 Danaher overview
  • FIG. 65 Hologic, Inc. overview
  • FIG. 66 Cepheid overview
  • FIG. 67 F. Hoffmann-La Roche Ltd overview
  • FIG. 68 Siemens Healthineers overview
  • FIG. 69 Stago overview
  • FIG. 70 Instrumentation Laboratory overview
  • FIG. 71 Leica Biosystems Nussloch Gmbh overview
Back to Top